IL6 and chronic myelogenous leukemia, BCR-ABL1 positive: Twelve of these thirteen lead compounds thus generated exhibited significant suppression of CML-AGE mediated upregulation of IL-6 and all of the compounds significantly suppressed the CML-AGE mediated upregulation of TNF-α [76].